Rolf Nüsing Selected Research

Patent Ductus Arteriosus

2/2003

Expression of prostanoid receptors in human ductus arteriosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rolf Nüsing Research Topics

Disease

5	Pain (Aches) 01/2020 - 08/2009
3	Inflammation (Inflammations) 10/2020 - 02/2014
2	Fibrosis (Cirrhosis) 10/2023 - 01/2022
2	Neoplasms (Cancer) 01/2022 - 10/2020
1	Thrombosis (Thrombus) 10/2023
1	Carotid Artery Injuries 10/2023
1	Angioedema 04/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Ureteral Obstruction 01/2022
1	Hydronephrosis 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Hypersensitivity (Allergy) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Eosinophilia 01/2020
1	Wounds and Injuries (Trauma) 02/2017
1	Neuralgia (Stump Neuralgia) 03/2014
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2014
1	Hyperalgesia 02/2014
1	Hypertension (High Blood Pressure) 12/2009
1	Atherosclerosis 11/2007
1	Congenital Heart Defects (Congenital Heart Defect) 02/2003
1	Patent Ductus Arteriosus 02/2003
1	Edema (Dropsy) 09/2002
1	Pulmonary Edema 09/2002
1	Acute Lung Injury 09/2002
1	Nephrocalcinosis 12/2001
1	Hypercalciuria 12/2001

Drug/Important Bio-Agent (IBA)

6	Epoprostenol (Prostacyclin)FDA LinkGeneric 10/2023 - 08/2009
6	Dinoprostone (PGE2)FDA Link 01/2022 - 02/2014
5	ProstaglandinsIBA 01/2022 - 09/2002
3	ThromboxanesIBA 01/2022 - 02/2003
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2017
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2020 - 09/2002
3	EicosanoidsIBA 01/2020 - 11/2007
2	LipidsIBA 01/2022 - 01/2020
2	Thromboxane Receptors (Thromboxane Receptor)IBA 01/2022 - 08/2009
2	EnzymesIBA 01/2020 - 01/2012
2	Cyclooxygenase 1IBA 02/2017 - 08/2009
2	Epoprostenol ReceptorsIBA 03/2014 - 08/2009
2	Prostaglandins EIBA 02/2003 - 09/2002
2	CalciumIBA 09/2002 - 12/2001
1	BradykininIBA 04/2022
1	Prostaglandin-E SynthasesIBA 01/2022
1	Thromboxane B2IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Glutamate DehydrogenaseIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017
1	Diclofenac (SR 38)FDA LinkGeneric 02/2017
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2014
1	InterleukinsIBA 03/2014
1	Meloxicam (Mobic)FDA LinkGeneric 03/2014
1	Cyclooxygenase InhibitorsIBA 03/2014
1	ZymosanIBA 02/2014
1	(2-(4-(4-isopropoxybenzyl)-phenylamino) imidazoline)IBA 02/2014
1	Dipyrone (Metamizole)IBA 01/2012
1	CannabinoidsIBA 01/2012
1	AmidesIBA 01/2012
1	phosducinIBA 12/2009
1	GTP-Binding Proteins (G-Protein)IBA 12/2009
1	Formaldehyde (Formol)FDA Link 08/2009
1	Prostaglandin Receptors (Prostaglandin Receptor)IBA 08/2009
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2007
1	Prostaglandins FIBA 02/2003
1	Prostaglandins DIBA 02/2003
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 09/2002
1	paxillineIBA 09/2002
1	Quinine (Quinson)FDA Link 09/2002
1	Potassium Channels (Potassium Channel)IBA 09/2002
1	Platelet Activating FactorIBA 09/2002
1	beta dendrotoxinIBA 09/2002
1	PotassiumIBA 09/2002
1	MagnesiumIBA 12/2001

Therapy/Procedure

1	Nephrectomy 01/2022
1	Therapeutics 01/2020
1	Intravenous Administration 02/2003
1	Intravenous Infusions 02/2003